Treatment of dermatomyositis with intravenous gammaglobulin.

No abstract is available for this paper.

• Publication year

  1991

• Venue

  American Journal of Medicine

• Publication date

  1991-08-01

• Fields of study

  Medicine

• Identifiers
  DOI 10.1016/0002-9343(91)90010-UPMID 1714236
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Benefit of intravenously administered immune serum globulin in patients with Guillain-Barré syndrome.

  1990cited by this paper
• Cyclosporin in juvenile dermatomyositis.

  1989cited by this paper
• Activation of complement and coagulation in juvenile dermatomyositis.

  1987cited by this paper
• Reversal of chronic polymyositis following intravenous immune serum globulin therapy.

  1987cited by this paper
• Dermatomyositis, polymyositis, and Coxsackie-B-virus infection.

  1987cited by this paper
• The treatment of Kawasaki syndrome with intravenous gamma globulin.

  1986cited by this paper
• The treatment of Kawasaki syndrome with intravenous gamma globulin.

  1986cited by this paper
• High-dose intravenous gammaglobulin for myasthenia gravis.

  1984cited by this paper
• High-dose intravenous gammaglobulin for myasthenia gravis.

  1984cited by this paper
• A murine model of polymyositis induced by coxsackievirus B1 (Tucson strain).

  1984cited by this paper
• Course of treated juvenile dermatomyositis.

  1984cited by this paper
• Anti-idiotypic immunity and autoimmunity. II. Idiotypic determinants of autoantibodies and lymphocytes in spontaneous and experimentally induced autoimmune thyroiditis.

  1983cited by this paper
• Anti‐idiotypic immunity and autoimmunity I. In vitro and in vivo effects of anti‐idiotypic antibodies to spontaneously occurring autoantibodies to rat thyroglobulin

  1981cited by this paper
• Immunosuppressive agents in corticosteroid‐refractory childhood dermatomyositis

  1980cited by this paper
• Methotrexate and azathioprine treatment of childhood dermatomyositis.

  1977cited by this paper
• Treatment of dermatomyositis in childhood.

  1976cited by this paper
• Polymyositis and dermatomyositis (first of two parts).

  1975cited by this paper
• Letter: Oral contraception and sex ratio at birth.

  1974cited by this paper
• AMPICILLIN-RESISTANT SHIGA BACILLUS IN BANGLADESH

  1974cited by this paper
• Prognosis in childhood dermatomyositis.

  1972cited by this paper
• Vascular deposits of immunoglobulin and complement in idiopathic inflammatory myopathy.

  1972cited by this paper
• DERMATOMYOSITIS (SYSTEMIC ANGIOPATHY) OF CHILDHOOD

  1966cited by this paper

• Immunotherapies in autoimmune inflammatory myopathies: Rationale and therapeutic updates.

  2026cites this paper
• Clinical use of intravenous immunoglobulin in juvenile dermatomyositis: indications, treatment course, and clinical outcomes

  2025cites this paper
• Immunobiologics in juvenile dermatomyositis: a systematic review of promising therapeutic advances

  2024cites this paper
• Autoimmune inflammatory myopathies.

  2023cites this paper
• Anti-Inflammatory and Immunomodulatory Effect of High-Dose Immunoglobulins in Children: From Approved Indications to Off-Label Use

  2023cites this paper
• Emerging Therapeutics in the Management of Connective Tissue Disease. Part II. Dermatomyositis and Scleroderma.

  2022cites this paper
• Early-onset juvenile dermatomyositis: A tertiary referral center experience and review of the literature.

  2022cites this paper
• Treatment of Calcinosis in Juvenile Dermatomyositis

  2021cites this paper
• Use of Rescue Therapy with IVIG or Cyclophosphamide in Juvenile Myositis

  2021cites this paper
• 68-year old woman with refractory cutaneous dermatomyositis

  2018cites this paper
• Update on the clinical management of juvenile dermatomyositis

  2018cites this paper
• Medications received by patients with juvenile dermatomyositis.

  2018cites this paper
• Biologic therapies for refractory juvenile dermatomyositis: five years of experience of the Childhood Arthritis and Rheumatology Research Alliance in North America

  2017cites this paper
• Critical review of the role of intravenous immunoglobulins in idiopathic inflammatory myopathies.

  2017cites this paper
• Treatment of Juvenile Dermatomyositis: An Update

  2017cites this paper
• 10 Immunoglobulin Treatment in Polymyositis and Dermatomyositis

  2017cites this paper
• Inmuno glo bulinas e ndo ve no s as e n las e nfe rme dade s auto inmune s s is té micas

  2016cites this paper
• Chapter 26 – Juvenile Dermatomyositis

  2016cites this paper
• Consensus-based recommendations for the management of juvenile dermatomyositis

  2016cites this paper
• Clinical efficacy of intravenous immunoglobulins for the treatment of dermatomyositis skin lesions without muscle disease

  2014cites this paper
• Перспективы применения внутривенного иммуног л обу л ина при аутоиммунных ревматических заболеваниях

  2014cites this paper
• [Biological therapy in idiopathic inflammatory myopathies].

  2014cites this paper
• A case of hypopharyngeal cancer associated with dermatomyositis

  2013cites this paper
• Update on the treatment of calcinosis in dermatomyositis.

  2013cites this paper
• [Intravenous immunoglobulin treatment in idiopathic inflammatory myopathy].

  2013cites this paper
• Calcinose universelle compliquant une dermatomyosite juvénile : amélioration sous immunoglobulines intraveineuses

  2013cites this paper
• Calcinosis universalis complicating juvenile dermatomyositis: improvement after intravenous immunoglobulin therapy.

  2013cites this paper
• Intervenous immunoglobulins as modulators of immune response : effect on T cell polarisation, pathogenicity and trafficking

  2012cites this paper
• Immunoglobulin Treatment in Polymyositis and Dermatomyositis

  2011cites this paper
• Chapter 24 – JUVENILE DERMATOMYOSITIS

  2011cites this paper
• Therapy of polymyositis and dermatomyositis.

  2011cites this paper
• Therapy of polymyositis and dermatomyositis.

  2011cites this paper
• PHARMACOLOGY AND DRUG THERAPY

  2011cites this paper
• Therapeutic approaches in the treatment of juvenile dermatomyositis in patients with recent-onset disease and in those experiencing disease flare: an international multicenter PRINTO study.

  2011cites this paper
• Efficacy of intravenous Ig therapy in juvenile dermatomyositis

  2011cites this paper
• Treatment Approaches to Juvenile Dermatomyositis (JDM) Across North America: The Childhood Arthritis and Rheumatology Research Alliance (CARRA) JDM Treatment Survey

  2010cites this paper
• Juvenile-Onset Clinically Amyopathic Dermatomyositis

  2010cites this paper
• CHAPTER 17 – Intravenous Immune Serum Globulin (IVIG) Therapy in Patients with Antibody Immune Deficiency

  2010cites this paper
• Neuromuscular Diseases Intravenous Immunoglobulin in Autoimmune

  2010cites this paper
• Disorders of Voluntary Muscle: Dystrophinopathies

  2010cites this paper
• Favorable outcome of juvenile dermatomyositis treated without systemic corticosteroids.

  2010cites this paper
• 9 ( CARRA ) JDM Treatment Survey America : The Childhood Arthritis and Rheumatology Research Alliance Treatment Approaches to Juvenile Dermatomyositis ( JDM ) Across North

  2010cites this paper
• Chapter 19 – Management of the Connective Tissue Diseases of Childhood

  2010cites this paper
• Dermatomyositis: current and future treatments

  2009cites this paper
• Juvenile Dermatomyositis: An Update on Clinical and Laboratory Findings

  2009cites this paper
• Systemic Lupus Erythematosus, Juvenile Dermatomyositis, Scleroderma, and Vasculitis

  2009cites this paper
• Fulminant and accelerated presentation of dermatomyositis in two previously healthy young adult males: a potential role for endotheliotropic viral infection

  2009cites this paper
• Improvement of juvenile dermatomyositis with calcinosis universalis after treatment with intravenous immunoglobulin

  2008cites this paper
• Safety of Intravenous Immunoglobulin in the Treatment of Juvenile Dermatomyositis: Adverse Reactions Are Associated With Immunoglobulin A Content

  2008cites this paper
• The treatment and prognosis of dermatomyositis: an updated review.

  2008cites this paper
• Parvovirus B19‐associated catastrophic endothelialitis with a Degos‐like presentation

  2008cites this paper
• [Current therapy for polymyositis and dermatomyositis].

  2008cites this paper
• Juvenile dermatomyositis and other idiopathic inflammatory myopathies of childhood.

  2008cites this paper
• Efficacy of high-dose intravenous immunoglobulin therapy in Japanese patients with steroid-resistant polymyositis and dermatomyositis

  2008cites this paper
• Inflammatory myopathies in children.

  2007cites this paper
• Studies of immunopathogenic mecha- nisms and treatment of chronic, inflam - matory myopathies, myositis

  2007cites this paper
• Intravenous immunoglobulin: properties, mode of action and practical use in dermatology.

  2007cites this paper
• Studies of immunopathogenic mechanisms and treatment of chronic, inflammatory myopathies, myositis

  2007cites this paper
• The use of i.v. IG therapy in dermatology

  2007cites this paper
• Limited effects of high-dose intravenous immunoglobulin (IVIG) treatment on molecular expression in muscle tissue of patients with inflammatory myopathies

  2007cites this paper
• Off-label uses of biologics in dermatology: interferon and intravenous immunoglobulin (part 1 of 2).

  2007cites this paper
• Clinical manifestations and pathogenesis of hydroxyapatite crystal deposition in juvenile dermatomyositis

  2006cites this paper
• Advances in the treatment of juvenile dermatomyositis

  2006cites this paper
• Successful treatment with regimen of intravenous gamma globulin and cyclophosphamide for dermatomyositis accompanied by interstitial pneumonia, opportunistic infection and steroid psychosis.

  2006cites this paper
• IVIG therapy in neurological disorders of childhood

  2006cites this paper
• Successful Treatment with Regimen of Intravenous Gammaglobulin and Cyclophosphamide for Dermatomyositis Accompanied by Interstitial Pneumonia, Opportunistic Infection and Steroid Psychosis.

  2006cites this paper
• Off-label uses of biologic agents in dermatology: a 2006 update.

  2006cites this paper
• Effect of rat kidney fraction 3 (rKF3) antigen and specific IgM antibody against rKF3 on the progression of slowly progressive Heymann nephritis

  2006cites this paper
• Management of Cutaneous Dermatomyositis

  2006cites this paper
• The role of high-dose immune globulin intravenous in the treatment of dermatomyositis.

  2006cites this paper
• i.v.-Immunglobuline bei chronischen idiopathischen Myositiden

  2005cites this paper
• International consensus guidelines for trials of therapies in the idiopathic inflammatory myopathies.

  2005cites this paper
• [Intravenous immunoglobulins in chronic idiopathic myositis].

  2005cites this paper
• Experience with monthly, high-dose, intravenous immunoglobulin therapy in patients with different connective tissue diseases

  2005cites this paper
• Efficacy of Intravenous Gammaglobulin Therapy in Inflammatory Myopathies Refractory to Conventional Treatments

  2005cites this paper
• CHAPTER 18 – JUVENILE DERMATOMYOSITIS

  2005cites this paper
• Long-term outcomes in juvenile dermatomyositis: How did we get here and where are we going?

  2005cites this paper
• Inflammatory myopathies in children.

  2005cites this paper
• Intravenous immunoglobulin in patients with anti-GAD antibody-associated neurological diseases and patients with inflammatory myopathies

  2005cites this paper
• Dalakas Neuromuscular Diseases Intravenous Immunoglobulin in Autoimmune

  2004cites this paper
• [Treatment by IgIV of polymyositis and dermatomyositis: literature review].

  2004cites this paper
• Treatment approaches to juvenile dermatomyositis

  2004cites this paper
• Molecular pathogenesis of inflammatory myopathies and future therapeutic strategies.

  2004cites this paper
• Intravenous immunoglobulin in autoimmune neuromuscular diseases.

  2004cites this paper
• Inmunoglobulinas endovenosas en las enfermedades autoinmunes sistémicas

  2003cites this paper
• Hypercapnic respiratory failure in systemic sclerosis.

  2003cites this paper
• High-dose intravenous immunoglobulin in inflammatory myopathies: experience based on controlled clinical trials

  2003cites this paper
• Treatment of idiopathic inflammatory myopathies

  2003cites this paper
• [Intravenous immunoglobulins in the systemic autoinmune diseases].

  2003cites this paper
• Presentation and management of idiopathic inflammatory muscle disease: four case reports and commentary from a series of 78 patients.

  2003cites this paper
• Intractable skin necrosis and interstitial pneumonia in amyopathic dermatomyositis, successfully treated with cyclosporin A.

  2003cites this paper
• Prospective study of high-dose intravenous immunoglobulin for the treatment of steroid-resistant polymyositis and dermatomyositis

  2003cites this paper
• Efficacy of pulsed intravenous immunoglobulin therapy in mixed connective tissue disease.

  2002cites this paper
• Percutaneous bone biopsy in the diagnosis of renal osteodystrophy.

  2002cites this paper
• Treatment of dermatomyositis and polymyositis.

  2002cites this paper
• High-dose intravenous immunoglobulin G treatment of myasthenia gravis

  2002cites this paper
• Treatment of Inflammatory Myopathies

  2002cites this paper
• [Juvenile dermatomyositis in the Nice area: a retrospective study 1991-2001].

  2002cites this paper
• The therapeutic uses of intravenous immunoglobulins in autoimmune rheumatic diseases.

  2002cites this paper
• Psoriasis: response to high‐dose intravenous immunoglobulin in three patients

  2002cites this paper